Goločorbin-Kon, Svetlana
Results 21-40 of 68 (Search time: 0.005 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 21 | 1-Dec-2018 | Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring | Svetlana Goločorbin-Kon ; Momir Mikov ; Jelena Helen Hogervorst ; Hani Al-Salami; Vladimir Maksimović |
| 22 | 1-Dec-2016 | The Effect of Diabetes and Hypertension on the Placental Permeation of the Hydrophilic Drug, Ranitidine | Mladena Lalić-Popović ; Jovana Paunković; Zorica Grujić ; Svetlana Goločorbin-Kon ; Velibor Vasović ; Hani Al-Salami; Momir Mikov |
| 23 | 1-Jan-2012 | Effect of simultaneous exposure to benzene and ethanol on urinary thioether excretion | Ivan Mikov ; Karmen Stankov ; Velibor Vasović ; Aleksandra Mikov ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 24 | 1-Nov-2018 | Eudragit-based microcapsules of probucol with a gut-bacterial processed secondary bile acid | Armin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Hani Al-Salami |
| 25 | 23-Aug-2018 | Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid | Mooranian, A.; Zamani, N.; Momir Mikov ; Svetlana Goločorbin-Kon ; Stojanović, Goran ; Arfuso, F.; Al-Salami, H. |
| 26 | 15-Nov-2016 | Evaluation of Dried Blood Spot technology in preclinical and clinical development | Elodie Mauchauffée; Cedric Poinsard; Emilie Borde; Momir Mikov ; Svetlana Goločorbin-Kon ; Dragan Spasić |
| 27 | 1-Jan-2019 | Formulation buoyancy of nanoencapsulated gliclazide using primary, conjugated and deconjugated bile acids | Mathavan S.; Ionescu C.; Božica Kovačević; Momir Mikov ; Svetlana Goločorbin-Kon ; Mooranian A.; Dass C.; Al-Salami H. |
| 28 | 1-Dec-2017 | High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect | Svetlana Goločorbin-Kon ; Jelena Calasan; Boris Milijašević ; Saša Vukmirović ; Mladena Lalić-Popović ; Momir Mikov ; Hani Al-Salami |
| 29 | 2019 | In silico alternatives to animal testing: state of the art | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Maja Đanić ; Bojan Stanimirov ; Mladena Lalić-Popović ; Momir Mikov |
| 30 | 1-Jan-2019 | In silico discovery of resveratrol analogues as potential agents in treatment of metabolic disorders | Nebojša Pavlović ; Maja Đanić ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Mladena Lalić-Popović ; Momir Mikov |
| 31 | 2018 | In vivo effects of ursodeoxycholic acid on doxorubicin-induced oxidative injury of hepatocyte | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 32 | 1-Apr-2019 | An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques | Armin Mooranian; Nassim Zamani; Ryu Takechi; Giuseppe Luna; Momir Mikov ; Svetlana Goločorbin-Kon ; Magdy Elnashar; Frank Arfuso; Hani Al-Salami |
| 33 | 1-Jan-2020 | The increasing doses of methotrexate pharmacokinetics after intravenous administration in rats - model selection | Ivana Rajšić; Nebojša Pavlović ; Boris Milijašević ; Saša Vukmirović ; Dragan Spasić ; Miodrag Žigić ; Nenad Grahovac ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 34 | 18-Jul-2016 | The influence of 12-monoketocholic acid on methotrexate oral absorption in the rat by means of fractional calculus | Momir Mikov ; Svetlana Goločorbin-Kon ; Nenad Grahovac ; Miodrag Žigić ; Dragan Spasić |
| 35 | 1-Jan-2008 | The influence of 3α,7α-dihydroxy-12-keto-5β-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes | Momir Mikov ; Hani Al-Salami; Svetlana Goločorbin-Kon ; Ranko Škrbić; Aleksandar Rašković ; Paul J. Fawcett |
| 36 | 1-Nov-2011 | The influence of probiotics on the cervical malignancy diagnostics quality | Živko Perišić; Nataša Perišić; Svetlana Goločorbin-Kon ; Dušan Vešović; Ana Mitrović Jovanović; Momir Mikov |
| 37 | 5-Jul-2012 | The influence of structural characteristics on the in vitro drug release rate of terbinafine from topical gels | Oana M.; Simona M.; Dumitru L.; Adriana M.; Goločorbin-Kon, Svetlana ; Ştefan R. |
| 38 | 1-Oct-2012 | An insight on differences in availability and reimbursement of orphan medicines among Serbia, Bulgaria and Sweden | Pavlović, Nebojša ; Stanimirov, Bojan ; Stojančević M.; Paut-Kusturica M.; Stoimenova A.; Goločorbin-Kon, Svetlana ; Mikov, Momir |
| 39 | 2014 | Interaction between different extracts of Hypericum perforatum L., from Serbia and pentobarbital, diazepam and paracetamol | Rašković, Aleksandar ; Cvejić, Jelena; Stilinović, Nebojša ; Goločorbin, Svetlana ; Vukmirović, Saša ; Mimica-Dukić, Neda |
| 40 | 1-Apr-2009 | Lamotrigine and valproate pharmacokinetics interactions in epileptic patients | Mladena Lalić-Popović ; Jelena Helen Hogervorst ; Jovan Popović; Ksenija Božić; Svetlana Goločorbin-Kon ; Hani Al-Salami; Momir Mikov |